The Medicines Patent Pool is delighted to participate in AIDS 2024, the 25th International AIDS Conference taking place in Munich, Germany and virtually from 22-26 July, as well as the pre-conference on 20 and 21 July. MPP will share a booth (#904) with Unitaid in the exhibition area.

AIDS 2024 will convene thousands of people living with, affected by and working on HIV to share knowledge, best practices and lessons learnt from the HIV response over the past 40 years, as well as from the responses to COVID-19, mpox and other public health threats.

AIDS 2024 in Munich, Germany, and virtually will provide a powerful platform to strategically align around a unified and equitable response to the pandemic. It will signal to the world that the HIV response is united behind an evidence-based approach that puts people first.

MPP colleagues will be actively participating in a number of sessions:

Pre-Conference

Saturday, 20 July, 8:00 – 9:00 | Room 14a / Channel 9
The PrEP product introduction landscape
Pre-conference session (session 1)
Esteban Burrone, Policy, Director, Strategy and Market Access, speaking as a panellist
More information

Conference

Monday, 22 July, 11:30 – 12:30 | Room 14a/Channel 9
Lessons learned from the DTG story
MPP/Unitaid satellite session
Esteban Burrone, Director, Policy, Strategy and Market Access, providing closing remarks
More information 

Tuesday, 23 July, 10:30 – 11:30 | Room 13b/Channel 7
The law, human rights and access to medicines
Oral abstract session | Track F: Political science, laws, ethics, policies and human rights
Mila Maistat, Senior Manager, Policy, Strategy and Market Access, providing introductory remarks
More information

Wednesday, 24 July, 18:00 – 19:30 | Hall B0a/Channel 4
An action plan to accelerate bNAbs for peri- and post-natal prophylaxis (PNP)
IAS, IAVI, Desmond Tutu Health Foundation satellite session
Sébastien Morin, Senior Manager, Policy, Strategy and Market Access, speaking as a panellist
More information

Friday, 26 July, 10:30 – 11:30 | Room 1/Channel 2
No retreat! No surrender! The urgency of aligning investments where they are needed the most in the global HIV response
Symposium | Track E: Implementation science, economics, systems and synergies
Lobna Gaayeb, Head of Scientific and Medical Affairs, moderating the session
More information

Friday, 26 July, 12:00 – 13:00 | Room 13b/Channel 7
Taking Action on Long-Acting Injectable PrEP: Towards access and implementation
Symposium | Track E: Implementation science, economics, systems and synergies
Esteban Burrone, Director, Policy, Strategy and Market, moderating the session
More information

Activities at the Booth, Exhibition Area and Global Village

MPP will share a booth (#904) with Unitaid in the exhibition area. Come and join us to know more about our activities!

Tuesday, 23 July, 11:30 – 12:00 | AVAC’s Research Literacy Zone at the Global Village (booth HT0401)
Process and considerations for generics licensing with MPP
Session organised by AVAC in collaboration with CS Caucus of LA PrEP Coalition
Sébastien Morin, Senior Manager, Policy, Strategy and Market Access, presenting

Wednesday, 24 July, 9:45 – 10:45 | Booth of France in the Exhibition Area (#804)
Accès équitable aux traitements et innovations contre le VIH : regards croisés sur les leçons apprises et défis à venir
Session organised by France, moderated by Anne-Claire Amprou, French Ambassador for Global Health
Esteban Burrone, Director, Policy, Strategy and Market, speaking

Wednesday, 24 July, 11:30 – 12:30 | Booth of MPP and Unitaid in the Exhibition Area (#904)
Direct from the Source: The DTG Film Story
Session organised by MPP
> Step behind the lens and experience the making of the “I am part of the DTG story” film. Meet and converse with the community heroes who shared their powerful stories during the cinema premiere at the World Health Assembly. Join us at the MPP booth for this enlightening session

Wednesday, 24 July, 13:15 – 14:00 | Booth of MPP and Unitaid in the Exhibition Area (#904)
#BetterMeds4Kids: Accelerating access to better HIV medicines for children
Session organised by MPP and partners of the Global Accelerator for Paediatric Formulations (GAP-f) WHO network
> Children are one of the most vulnerable yet neglected populations in terms of access to optimal medicines in adapted formulations. Consequently, paediatric therapies often remain limited and sub-optimal. Hear from partners of the Global Accelerator for Paediatric Formulations (GAP-f) WHO network, of which MPP is a founding member, as they share their experiences in addressing innovation and access challenges in developing and improving access to HIV medicines for children.

Thursday, 25 July, 11:00 – 12:00 | Booth of MPP and Unitaid in the Exhibition Area (#904)
NAVIGATING LONG-ACTING THERAPEUTICS: LAPaL, a database at the Intersection of Innovation and Access
Session organised by MPP
> LAPaL is the only online open access tool dedicated to supporting access to long-acting therapeutics. It not only provides patent and licensing information about key long-acting technologies and compounds, but also captures clinical development, regulatory filing information of selected treatment and prevention medicines. LAPaL aim is to provide reliable information and support innovation in the long-acting therapeutics while fostering access. Join this hands-on session to discover it! If possible, come with your computer/tablet to get the full experience!